Experimental and clinical studies with diazoxide.
D000361:Agammaglobulinemia / Q000139:chemically induced; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003981:Diazoxide / Q000009:adverse effects / Q000494:pharmacology*; D004285:Dogs; D004487:Edema / Q000139:chemically induced; D004827:Epilepsy / Q000139:chemically induced; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000139:chemically induced; D007275:Injections, Intravenous; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000187:drug effects*; D007970:Leukopenia / Q000139:chemically induced; D009638:Norepinephrine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology
D001786:Blood Glucose; D007328:Insulin; D003981:Diazoxide; D011188:Potassium; D009638:Norepinephrine; D004837:Epinephrine